Proteon logo     Print Page | Close Window

SEC Filings

PROTEON THERAPEUTICS INC filed this Form S-1 on 09/16/2014
Entire Document

Exhibit 10.11


NIH Sponsored Invention


This Agreement, effective this 4th day of February 2002, is between the Johns Hopkins University, a corporation of the State of Maryland, having a principle place of business at 720 Rutland Avenue, Baltimore, Maryland 21205 (hereinafter referred to as “JHU”) and F. Nicholas Franano, an individual, residing at 1010 W. 69th Terrace, Kansas City, MO 64113 (hereinafter referred to as “FRANANO”).




WHEREAS, a valuable invention entitled “Local, Transcatheter Delivery of Proteases to Reopen Obstructed Biological Conduits” JHU Ref. No. DM-3578 (hereinafter Invention) was developed during the course of research conducted by FRANANO, and is disclosed and/or claimed in U.S. Provisional Patent Application Serial No. 60,155,938 filed on September 24, 1999, U.S. Patent Application Serial No 09,669,051 filed on September 24, 2000 and International PCT Application Serial No. PCT/US00/26237 filed on September 24, 2000 (hereinafter Patent Rights); and


WHEREAS, JHU has acquired through assignment all rights to all JHU inventors’ interest said valuable Invention; and


WHEREAS, JHU has determined that commercialization of said invention is best served by releasing title back to FRANANO; and


WHEREAS, FRANANO desires to obtain all rights in said invention to pursue commercialization throughout the world;


NOW, THEREFORE, in consideration of the foregoing premises and the following mutual covenants, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties hereto agree as follows:





1.1                               JHU hereby assigns all of its intellectual property rights in the Invention to FRANANO, subject to the terms of this agreement and JHU’s receipt of any payments as provided for below; the rights retained by the United States government in accordance with P.L. 96-517, as amended by P.L. 98-620; and subject to the approval of the U.S. government under 37 CFR 401.9. This assignment is contingent upon the accuracy of the Report of Invention provided to the Office of Technology Licensing (including, but not